Company intelligence / Profile preview

NuChem Sciences

Montreal/St. Laurent, Quebec, Canadanuchemsciences.com ↗

Ownership: Private
Employees: ~180
Development stage: Preclinical

Overview

Provides contract research services in medicinal chemistry and drug discovery biology to biotech and pharma companies. Not a therapeutics developer with its own clinical pipeline. Has contributed to projects such as small molecule inhibitors for rare ovarian cancer in partnership with AmorChem and McGill University. No direct clinical results—enables client programs.

Therapeutic areas: OncologyEndocrinologyImmunologyRheumatologyNeurologyInfectious Diseases
Modalities: Small moleculePeptidesBiologic
Industry: Drug Discovery Services

Partnerships

AmorChem venture fund/McGill University collaboration on small molecule oncology program targeting SMARCA4-deficient cancers.

Beyond the preview

Go deeper on NuChem Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NuChem Sciences.

Explore the full profile